Concerning breast cancer, these authors observed a virtually complete mutual exclusivity between TP53 mutations and CDH1 alterations and a partial exclusivity between TP53 mutations and MAP3K1 and also, in part, PIK3CA mutations [325]. This evidence concerns the gene CDH1 and breast cancer.